ÄãºÃ£¬»¶Ó­À´µ½¾­¹ÜÖ®¼Ò [µÇ¼] [×¢²á]

ÉèΪÊ×Ò³ | ¾­¹ÜÖ®¼ÒÊ×Ò³ | Êղر¾Õ¾

±±¾©´óѧҩѧԺҩ¼Áѧרҵ˶ʿÑо¿Éúµ¼Ê¦ÐÅÏ¢£ºÍõ¼á³É

·¢²¼Ê±¼ä£º2015-01-05 À´Ô´£ºÈË´ó¾­¼ÃÂÛ̳
Íõ¼á³É ¸±½ÌÊÚ¡¢Ë¶Ê¿Éúµ¼Ê¦ Asso. Prof. Jian-Cheng Wang Tel & Fax : (010) 8280 2683 (Office)£»8280 5764 (Lab) Email: wang-jc@bjmu.edu.cn 1992Äê9Ô¡ª1997Äê7Ô ±±¾©Ò½¿Æ´óѧ ҩѧԺӦÓû¯Ñ§×¨Òµ£¬»ñѧʿѧλ£»1997Äê8Ô¡ª1999Äê8Ô£¬ÁôУÔÚÔ­±±¾©Ò½¿Æ´óѧҩѧԺѧÉú°ì¹«ÊÒµ£ÈÎѧÉú¸¨µ¼Ô±£¬Öú½Ì£»1999Äê9Ô¡ª2004Äê6Ô ±±¾©´óѧ ҩѧԺҩ¼Áѧרҵ£¬»ñ²©Ê¿Ñ§Î»£¬ÔøÓÚ2002Äê7Ô¡ª2004Äê4ԠмÓƹúÁ¢´óѧҽѧԺ×÷Ϊ¹ú¼ÊÁªºÏÅàÑø²©Ê¿Éú¡£ 2004Äê8Ô£¬ÁôУÈνÌÊÜƸΪ½²Ê¦£¬2007Äê8ÔÂÖÁ½ñÊÜƸΪ¸±½ÌÊÚ£¬´ÓÊÂÒ©¼Áѧ½Ìѧ¿ÆÑй¤×÷£¬Ö÷Òª³Ðµ£±¾¿ÆÉúºÍÑо¿ÉúµÄÒ©¼Áѧ¿Î³Ì½ÌѧÈÎÎñºÍÒ©ÎïмÁÐÍÓëм¼ÊõµÄÑо¿¿ª·¢¹¤×÷¡£ Ôø²Î¼Ó¹ú¼Ò95¿ÆÑй¥¹ØÏîÄ¿¡¢863¿ÎÌâÑо¿ÏîÄ¿¡¢×ÔÈ»¿Æѧ»ù½ðÖØ´ó¿ÆÑÐÏîÄ¿Ñо¿¡¢½ÌÓý²¿ÖØ´óÑо¿ÅàÓý¼Æ»®ÏîÄ¿¡£×÷ΪÏîÄ¿¸ºÔðÈËÒÑÍê³É¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÇàÄêÏîÄ¿1Ï±±¾©ÊÐ×ÔÈ»¿Æѧ»ù½ðԤ̽Ë÷ÏîÄ¿1Ï½ÌÓý²¿Ð½Ìʦ¿ÆÑлù½ð1Ï±±¾©ÊпÆί¿Æ¼¼¹¥¹Ø¿ÎÌâ1Ïî¡£ÏÖ¸ºÔðÖ´Ðйú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿1Ï±±¾©ÊÐ×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿1ÏÏÖ²ÎÓë973ÖØ´óÑо¿¼Æ»®ÏîÄ¿2Ïµ¼ÏòÐÔÄÉÃ×ÔØҩϵͳ¼°ÆäÔÚÄÔ²¿¼²²¡ÖÎÁÆÓ¦Óûù´¡Ñо¿2007CB935800ºÍÄÉÃ×¼¼Êõ¸ÄÉÆÄÑÈÜÐÔÒ©ÎïÌåÄÚÎüÊÕ¹¦Ð§»ù´¡Ñо¿2009CB930300£©£¬²ÎÓë¹ú¼ÒÖØ´óÐÂÒ©´´ÖÆרÏîмÁÐÍÓëÐÂÊÍҩϵͳ¼¼Êõƽ̨ÏîÄ¿¡£ÒÑÍê³É»òÕýÔÚÖ÷³Ö²úÒµ»¯ÏîÄ¿10ÓàÏ»ñÐÂÒ©Ö¤Êé1ÏÁÙ´²Åú¼þ2¼þ£¬×¨ÀûÖ¤Êé2¼þ£¬ÉêÇëרÀû10ÓàÏî¡£ÒÑ·¢±í¹úÄÚÍ⿯ÎïѧÊõÂÛÎÄ50Óàƪ£¬³ö°æѧÊõºÏÖø1 ²¿£¬ÒëÖø1²¿¡£ 2008Äê»ñÖйúҩѧ»á¿Æѧ¼¼Êõ½±Ò»µÈ½±£¬¡¶ÐÂÐ͸øҩϵͳµÄÑо¿¡·£¨µÚÈýÍê³ÉÈË£©£»2008ÄêÈëÑ¡±±¾©ÊпƼ¼ÐÂÐÇÈ˲żƻ®£¨¸öÈË£©£»2009Äê»ñ±±¾©´óѧҽѧ²¿ÓÅÐãÇàÄêѧÕߣ¨¸öÈË£©£»2009ÄêÖйúҩѧ»á-ʯҩ¼¯ÍÅÇàÄêÒ©¼Áѧ½±£¨¸öÈ˽±£©£»2010Äê »ñ½ÌÓý²¿¿Æ¼¼½ø²½Ò»µÈ½±£¬¡¶¿¹Ö×ÁöÓëÖ×Áö¸Éϸ°û¶àÒ©ÄÍÒ©ÐÔ³¤Ñ­»·ÔØÒ©Ö¬ÖÊÌå¸øҩϵͳµÄÑо¿¡·£¨µÚÈýÍê³ÉÈË£©£»2011ÄêÈëÑ¡½ÌÓý²¿ÐÂÊÀ¼ÍÓÅÐãÈ˲ÅÖ§³Ö¼Æ»®¡£ 2010ÄêÊÜƸΪ¡¶ÖлªÒ½Ñ§°Ù¿ÆÈ«ÊéÒ©¼Áѧ·Ö¾í¡·¸±Ö÷±à¼æѧÊõÃØÊ飬SFDAÒ½ÁÆÆ÷е£¨Ò©Ðµ×飩ÉóÆÀר¼Ò£¬Öйúҩѧ»á¡¶È«ÇòҩѶ¡·ÆÚ¿¯±àί¡£µ£ÈÎÈô¸É¹úÄÚÍâÆÚ¿¯ÔÓÖ¾Éó¸åÈË¡£ Ñо¿ÁìÓò£º¸ÄÉÆÉúÎï´ó·Ö×ÓÒ©Îµ°°×¶àëĺÍsiRNA£©ÌåÄÚ¹¦Ð§µÄÐÂÐÍÔØÌå¸øҩϵͳµÄÑо¿¡¢°ÐÏòÐÔÄÉÃ×Ò©Îï´«µÝϵͳµÄÑо¿¡£ ´ú±íÐÔÂÛÎÄ£º 1. Jiang J, Yang SJ, Wang JC*, Yang LJ, Xu ZZ, Yang T, Liu XY, Zhang Q. Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin. European Journal of Pharmaceutics and Biopharmaceutics. 2010,76(2):170-8. 2. Zhang YF, Wang JC*, Bian DY, Zhang X, Zhang Q., Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: In vitro and in vivo studies£¬European Journal of Pharmaceutics and Biopharmaceutics, 2010, 74: 467-473 3. Hui Zhao, Jian-Cheng Wang*, Qi-Shi Sun, Chun-Lei Luo, Shu-Feng Zhou, Qiang Zhang* £¬RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted human ovarian cancer. Journal of Drug Targeting, 2009£¬17(1)£¬10-18 4. Mao-Bo Cheng, Jian-Cheng Wang*, Yu-Hua Li, Xiao-Yan Liu, Xuan Zhang, Da-Wei Chen, Shu-Feng Zhou, Qiang Zhang,Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme. Journal of Controlled Release, 2008,129(1):41-8 5. Juan-Li Lu, Jian-Cheng Wang*, Shu-Xin Zhao, Xiao-Yan Liu, Hui Zhao, Xuan Zhang, Shu-Feng Zhou, Qiang Zhang, Self-Microemulsifying Drug Delivery System (SMEDDS) Improves Anticancer Effect of oral 9-nitrocamptothecin on Human Cancer Xenografts in Nude Mice, European Journal of Pharmaceutics and Biopharmaceutics,2008,69(3):899-907 6. Ai-Ping Zheng, Jian-Cheng Wang*, Wan-Liang Lu, Xuan Zhang, Hua Zhang, Xue-Qing Wang, and Qiang Zhang Thymopentin-Loaded pH-Sensitive Chitosan Nanoparticles for Oral Administration: Preparation, Characterization,and Pharmacodynamics. Journal of Nanoscience and Nanotechnology(10/9)6:2936¨C2944, 2006£¨ÔðÈÎ×÷Õߣ© 7. Jian-Cheng Wang, Xiao-Yan Liu, Wan-Liang Lu, Alex Chang, Qiang Zhang£¬Boon-Cher Goh, How-Sung Lee. Pharmacokinetics of intravenously administered stealth liposomal doxorubicin modulated with verapamil in rats.  European Journal of Pharmaceutics and Biopharmaceutics 62 :44-51  2006£¨µÚÒ»×÷Õߣ©£¨SCI IF2005=2.525£© 8. JianCheng WANG, BoonCher GOH, WanLiang LU, Qiang ZHANG, Alex CHANG,Xiao Yan LIU, Theresa MC TAN, HowSung LEE. In Vitro Cytotoxicity of Stealth Liposomes Co-encapsulating Doxorubicin and Verapamil on Doxorubicin-Resistant Tumor Cells Biol. Pharm. Bull. 28(5): 822¡ª828 ,2005.£¨µÚÒ»×÷Õߣ©£¨SCI=1.392£© 9. Íõ¼á³É¡¢ÕÅÇ¿Ö÷Ò룬¡¶ÄÉÃ×Á£Ò©ÎïÊäËÍϵͳ¡·£¬±±¾©´óѧҽѧ³ö°æÉ磬2010Äê9Ô³ö°æ
¾­¹ÜÖ®¼Ò¡°Ñ§µÀ»á¡±Ð¡³ÌÐò
  • ɨÂë¼ÓÈë¡°¿¼ÑÐѧϰ±Ê¼ÇȺ¡±
ÍƼöÔĶÁ
¾­¼ÃѧÏà¹ØÎÄÕÂ
±êÇ©ÔÆ
¾­¹ÜÖ®¼Ò¾«²ÊÎÄÕÂÍƼö